[Edaily Reporter Shin Ha-yeon ] LAMEDITECH Co., Ltd.(462510)announced on the 29th that its laser-based blood glucose meter, “HandyRay Glu,” is rapidly establishing itself in the domestic blood glucose management market, having expanded its online and offline distribution networks and secured use cases in medical settings just one month after its launch.

According to the company, HandyRay Glu has recently expanded its sales channels to include pharmacies nationwide and medical device specialty stores near hospitals. The company also successfully concluded its crowdfunding campaign on the Wadiz platform, exceeding its funding goal.

HandyRay Glu is a product designed to enhance the convenience of blood sampling and measurement in the blood glucose management process. Since its launch, the company has been expanding its online sales channels while actively entering the nationwide pharmacy distribution network. Recently, it has also begun supplying the product to medical device specialty stores near Jongno and hospitals, further improving consumer accessibility.

Its scope of use is also expanding in medical settings. HandyRay Glu is not only used by local internal medicine clinics to measure blood glucose levels in diabetic patients but is also utilized as an educational tool in patient education programs at the diabetes education centers of Samsung Seoul Hospital and Asan Medical Center in Seoul, supporting diabetic patients in learning proper blood glucose measurement techniques and self-management.

A representative from LAMEDITECH Co., Ltd. stated, “Just one month after its launch, the product is receiving positive feedback from both the consumer market and the medical field, confirming its competitiveness,” adding, “We will continue to expand our offline distribution network centered on pharmacies and medical institutions so that more patients with diabetes can conveniently manage their blood glucose levels.”